Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Glory Coppe
Atherosclerosis, a chronic immune-inflammatory and age-related disorder characterized by lipid-rich plaques in arterial walls, remains the leading cause of global mortality. While advances in cardiology have improved our understanding of atherosclerosis, the underlying mechanisms continue to be complex. Recently, emerging evidence has shed light on the critical role of cellular senescence in this pathological process. Cellular senescence is characterized by irreversible cell cycle arrest and distinct phenotypic alterations, along with the production of senescence-associated secretory phenotype (SASP) factors, contributing to pro-inflammatory and pro-atherosclerotic responses. This review aims to provide an extensive examination of the current evidence regarding cellular senescence in atherosclerosis, focusing on its role in endothelial cells (ECs), vascular smooth muscle cells (VSMCs). We discuss the various causative stimuli for cellular senescence in atherosclerosis, including hyperlipidemia, hypertension, diabetes, obesity, DNA damage, oncogene signals, and mitochondrial dysfunction. Moreover, we explore the interplay between cellular senescence and atherosclerosis, emphasizing the involvement of senescent cells in the pathophysiological process. This comprehensive review aims to enhance our understanding of the molecular mechanisms underlying atherosclerosis and shed light on potential therapeutic strategies targeting cellular senescence for the prevention and treatment of this life-threatening disease.